StockClub

ALPMF

ALPMFAstellas Pharma Inc.$ --
Astellas Pharma Inc.

Astellas Pharma Inc.

ALPMF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2026 Q3Updated: 12/31/2025

Revenue

attach_money
571,704M JPY
-

Operating Income

trending_up
124,812M JPY
-

Net Income

verified
100,411M JPY
-

EPS

paid
56.09JPY
-

Revenue

JPY571.7B

BEAT
JPY456.7B
JPY505.8B
Q1
JPY488B
JPY531.8B
Q2
JPY530.3B
JPY571.7B
Q3
JPY1.5T
JPY1.6T
Cumulative
Estimate (Forecast)Actual (Actual)
FY2026 Q3 YoY
- JPY-

Net Income

JPY100.4B

BEAT
JPY35.9B
JPY68.4B
Q1
JPY54.3B
JPY80.3B
Q2
JPY82.6B
JPY100.4B
Q3
JPY172.8B
JPY249.2B
Cumulative
Estimate (Forecast)Actual (Actual)
FY2026 Q3 YoY
- JPY-

Surprise History

ActualEstimate
FY2025BEAT
JPY1.9T

Future Forecast